[HTML] jci.org

[HTML][HTML] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …
被引用次数：36 相关文章

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies

A Mazzoni, A Vanni, M Spinicci, G Lamacchia… - THE JOURNAL OF …, 2022 - flore.unifi.it
Background: Immunization against SARS-CoV-2, the causative agent of coronavirus
disease-19 (COVID-19) occurs via natural infection or vaccination. However, it is currently …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci… - The Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …

SARS-CoV-2 infection and vaccination trigger longlived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci… - Journal of Clinical …, 2022 - search.proquest.com
BACKGROUND. Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …
[PDF] ucv.ve

[PDF][PDF] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4 T lymphocytes: implications for booster strategies

A Mazzoni, GM Rossolini, F Annunziato - sostelemedicina.ucv.ve
(COVID-19) occurs via natural infection or vaccination. However, it is currently unknown how
long infection-or vaccination-induced immunological memory will last. METHODS. We …

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.

A Mazzoni, A Vanni, M Spinicci… - The Journal of …, 2022 - europepmc.org
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …

SARS-CoV-2 infection and vaccination trigger long-lived B and [CD4. sup.+] T lymphocytes with implications for booster strategies.

A Mazzoni, A Vanni, M Spinicci, G Lamacchia… - Journal of Clinical …, 2022 - go.gale.com
BACKGROUND. Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDImmunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.

A Mazzoni, A Vanni, M Spinicci, G Lamacchia, ST Kiros… - 2022 - cabidigitallibrary.org
Abstract BACKGROUND. Immunization against SARS-CoV-2, the causative agent of COVID-
19, occurs via natural infection or vaccination. However, it is currently unknown how long …
[PDF] academia.edu

[PDF][PDF] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

A Mazzoni, A Vanni, M Spinicci, G Lamacchia, ST Kiros… - 2022 - academia.edu
BACKGROUND. Immunization against SARS-CoV-2, the causative agent of COVID-19,
occurs via natural infection or vaccination. However, it is currently unknown how long …